615 related articles for article (PubMed ID: 17884626)
1. Little biotech on the prairie.
Wolfson W
Chem Biol; 2007 Sep; 14(9):969-71. PubMed ID: 17884626
[No Abstract] [Full Text] [Related]
2. Biotech slumps in Q1.
Lawrence S
Nat Biotechnol; 2008 May; 26(5):486. PubMed ID: 18464769
[No Abstract] [Full Text] [Related]
3. Early-stage returns?
Booth BL
Nat Biotechnol; 2006 Nov; 24(11):1335-40. PubMed ID: 17093473
[TBL] [Abstract][Full Text] [Related]
4. Biotech's wonder ride.
Rynecki D
Fortune; 2000 Mar; 141(5):435-6. PubMed ID: 10788046
[No Abstract] [Full Text] [Related]
5. Bugs or drugs, tortoises or hares?
Jacobs T
Nat Biotechnol; 2005 Mar; 23(3):293. PubMed ID: 15765079
[No Abstract] [Full Text] [Related]
6. The stampede to convertibles.
Jacobs T
Nat Biotechnol; 2003 Aug; 21(8):855. PubMed ID: 12894195
[No Abstract] [Full Text] [Related]
7. Biotechs hold their own in shifting industry.
Mitchell P
Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238
[No Abstract] [Full Text] [Related]
8. Any diamonds in the diagnostic coal?
Jacobs T
Nat Biotechnol; 2006 Aug; 24(8):930. PubMed ID: 16900133
[No Abstract] [Full Text] [Related]
9. Biotech business Down Under.
Beckley C
Nature; 2004 Jun; 429(6991 Suppl):5-9. PubMed ID: 15175704
[No Abstract] [Full Text] [Related]
10. Sustaining agbiotechnology through lean times.
McElroy D
Nat Biotechnol; 2003 Sep; 21(9):996-1002. PubMed ID: 12949560
[No Abstract] [Full Text] [Related]
11. Divining the path to a successful European exit.
Buch HK; Gustafsson AC; Drvota V; Sundberg CJ
Nat Biotechnol; 2011 Mar; 29(3):205-7. PubMed ID: 21510008
[No Abstract] [Full Text] [Related]
12. A rollercoaster ride.
Jacobs T
Nat Biotechnol; 2006 Mar; 24(3):284. PubMed ID: 16525390
[No Abstract] [Full Text] [Related]
13. China's biotech experiments.
Hepeng J
Nat Biotechnol; 2005 Dec; 23(12):1472-3. PubMed ID: 16421994
[No Abstract] [Full Text] [Related]
14. Biotech meets the investors.
Berry S
Trends Biotechnol; 2002 Sep; 20(9):370-1. PubMed ID: 12175762
[No Abstract] [Full Text] [Related]
15. Silent running: the race to the clinic.
Nature; 2006 Aug; 442(7103):614-5. PubMed ID: 16900171
[No Abstract] [Full Text] [Related]
16. Japanese firms broaden investment focus to early biotech.
Louët S; Sipp D
Nat Biotechnol; 2004 Aug; 22(8):931-2. PubMed ID: 15286631
[No Abstract] [Full Text] [Related]
17. Shutters come off IPO window.
Hodgson J
Nat Biotechnol; 2002 Jan; 20(1):6. PubMed ID: 11753342
[No Abstract] [Full Text] [Related]
18. Biotech round the world: focus on Canada.
Biotechnol J; 2008 Jul; 3(7):848-51. PubMed ID: 18624341
[No Abstract] [Full Text] [Related]
19. Europe's biotech renaissance.
Senior M
Nat Biotechnol; 2020 Apr; 38(4):408-415. PubMed ID: 32265563
[No Abstract] [Full Text] [Related]
20. 25 top health care stocks. Will they lead the next market boom?
Kane L
Med Econ; 2001 Apr; 78(7):126-8, 133-6, 140-2. PubMed ID: 11368040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
